Exhibitors Search
ZINCURE
|
Exhibition
|
|
|---|---|
|
Booth no.
|
A60 |
|
Country
|
Korea, South |
|
Address
|
|
|
Tel
|
<02-3408-3648 |
|
Exhibits
|
리조좀 기능회복을 이용한 퇴행성 뇌질환 치료제 개발 |
|
Company Type
|
Exhibitor Information
ZINCURE is a Biotech Company Developing Therapies for Acute and Degenerative Brain Diseases Through Zinc Homeostasis Regulation.
Our lead program focuses on a therapeutic candidate for Amyotrophic Lateral Sclerosis (ALS), while expanding into broader neurodegenerative disease areas.
Our lead program focuses on a therapeutic candidate for Amyotrophic Lateral Sclerosis (ALS), while expanding into broader neurodegenerative disease areas.
Exhibit/Technology Introduction (General)
Lsosome activation plays the key role in the pathogenesis of neurodegenerative diseases
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : ysosome may play the key role in the pathogenesis of neurodegenerative diseasesysosome may play the key role in the pathogenesis of neurodegenerative diseases
KYUNGYON EXHIBITION CORP.